Vertex Pharmaceuticals (VRTX) earnings

Earnings (net income) · fiscal 2025
$3.95B

Vertex Pharmaceuticals (VRTX) reported net income of $3.95B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$535.60M. Figures as of 18 Nov 2026, 02:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$3.95B
Growth, 5 years
+7.8% a year
Highest on record
$3.95Bfiscal 2025
Lowest on record
-$754.63Mfiscal 2010
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vertex Pharmaceuticals earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 7.8% a year. Across the 18 fiscal years on record (2008–2025), the highest was $3.95B in fiscal 2025 and the lowest -$754.63M in fiscal 2010.

History · 18 fiscal years

Earnings (net income) by fiscal year

Vertex Pharmaceuticals earnings, year by year

Vertex Pharmaceuticals (VRTX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$3.95B—
2024-$535.60M 114.8% down
2023$3.62B 9.0% up
2022$3.32B 41.8% up
2021$2.34B 13.6% down
2020$2.71B 130.4% up
2019$1.18B 43.9% down
2018$2.10B 695.8% up
2017$263.48M—
2016-$112.05M—
2015-$556.33M—
2014-$738.56M—
2013-$445.03M—
2012-$107.03M 461.9% down
2011$29.57M—
2010-$754.63M—
2009-$642.18M—
2008-$459.85M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Vertex Pharmaceuticals and comparable companies
CompanyEarnings (net income)Fiscal year
Pfizer PFE$7.77B2025
Danaher DHR$3.61B2025
Intuitive Surgical ISRG$2.86B2025
Vertex Pharmaceuticals VRTX$3.95B2025
Medtronic MDT$4.80B2026
Bristol-Myers Squibb BMY$7.05B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals earnings: questions and answers

What is Vertex Pharmaceuticals's net income?

Vertex Pharmaceuticals (VRTX) reported net income of $3.95B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$535.60M.

What is the growth rate of Vertex Pharmaceuticals's net income?

Over the five fiscal years to 2025 net income grew at a compound 7.8% a year.

What are the highest and lowest net income figures on record for Vertex Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was $3.95B in fiscal 2025 and the lowest -$754.63M in fiscal 2010.

How is Vertex Pharmaceuticals's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.